Aytu BioPharma Inc.

NASDAQ: AYTU · Real-Time Price · USD
2.21
0.02 (0.91%)
At close: Aug 15, 2025, 3:59 PM
2.24
1.36%
After-hours: Aug 15, 2025, 05:41 PM EDT

Aytu BioPharma Cash Flow Statement

Financials in USD. Fiscal year is July - June.
Fiscal Year Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020
Net Income
3.99M 788K 1.47M -4.62M -2.89M -220K -8.12M -2.46M -7.2M -4.51M -2.88M -17.7M -53.07M -11.55M -27.85M -19M -25.46M -9.53M -4.31M
Depreciation & Amortization
1.32M 1.34M 1.43M 2.57M 1.8M 2.18M 2.23M 2.12M 2.19M 2.18M 2.33M 2.25M 2.65M 2.67M 2.68M -1.1M 6.29M 1.92M 2.09M
Stock-Based Compensation
139K 151K 173K 352K 811K 707K 930K 900K 902K 3.07M 1.18M 1.23M 1.27M 1.23M 1.52M 1.09M 1.52M 508K 455K
Other Working Capital
-370K 5.18M -4.81M -10.35M 1.38M -99K -297K -765K 9.04M -336K -5.35M -13.72M 5.17M -6.21M 3.75M -4.76M 2.17M 2.24M 945.06K
Other Non-Cash Items
-11.9M -227K -3.41M 947K 4.98M 110K 6.12M -326K -3.09M -709K 311K 13.34M 43.54M 87K -3K -6.78M -653.21K 3.31M -345.52K
Deferred Income Tax
n/a n/a n/a n/a n/a 659K -20K 6.67M n/a n/a n/a -19.75M n/a 96K 19.66M 14.4M 7.41M 404.78K 112.52K
Change in Working Capital
n/a 854K -854K -42K 416K -3.68M -1.35M 2.46M 4.29M -2.46M -10.08M -6.21M -3.5M -1.36M 211K 5.1M 2.11M 453.16K -5.98M
Operating Cash Flow
-6.46M 2.9M -1.19M -788K -254K -135K -211K 9.37M -2.91M -2.44M -9.15M -7.09M -9.12M -8.82M -3.79M -6.29M -8.78M -2.93M -7.97M
Capital Expenditures
-69K -6K -136K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -2.34M n/a n/a n/a
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a -5K 5K -5K n/a -40K -29K -3.06M -50K -2.46M -317.41K -23.62K -19.14K
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a 151K 517K -34K -45K -174K -76K -150K -4K -5K 42K -1K -41K 8K -36K 43.92K -640.48K -6.12K 2.2K
Investing Cash Flow
-69K 145K 381K -34K -45K -174K -76K -155K 1K -5K 42K -41K -70K -3.05M -86K -2.42M -317.41K -29.74K -16.94K
Debt Repayment
n/a -723K 1.41M -15.65M 530K -212K -22K -9.01M 2.9M -632K 4.25M 402K n/a 2.22M -3.44M 2.55M -6.26M -137K -136K
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
4.99M -2.04M -500K 13.34M n/a n/a -2.71M 1.04M -1.76M -2.39M -1.11M -513K -6.35M -151K -2.33M 9.27M -136.03K -5.04M -2.04M
Financial Cash Flow
4.3M -2.76M 911K 1.07M 530K -126K -2.73M -5.4M 2.58M -1.86M 13.56M -1.12M 1.52M 6.59M -5.46M 11.81M -6.4M 27.08M -2.18M
Net Cash Flow
-2.23M 290K 102K 246K 231K -435K -3.02M 3.81M -322K -4.31M 4.45M -8.25M -7.66M -5.28M -9.34M 3.11M -15.49M 24.12M -10.17M
Free Cash Flow
-6.52M 2.9M -1.33M -788K -254K -135K -211K 9.37M -2.91M -2.44M -9.15M -7.09M -9.12M -8.82M -3.79M -8.63M -8.78M -2.93M -7.97M